fig3
![Comparative effects of canagliflozin and sitagliptin in chronically ischemic myocardium](https://image.oaes.cc/86f2c794-f7a4-470b-a892-451b19dcdbe8/vp8095.fig.3.jpg)
Figure 3. Sitagliptin increases coronary microvessel collateralization in chronically ischemic myocardium compared to canagliflozin. Capillary and arteriolar density in swine treated with canagliflozin (CANA, eight animals), sitagliptin (SIT, five animals), and vehicle containing no medication (CON, seven animals) shown on box and whisker plots.